Abrahão Alves de Oliveira Filho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abrahão Alves de Oliveira Filho has a total of 521 co-authors. Here are the top co-authors by number of shared publications:
- Aleson Pereira de Sousa
Universidade Federal da Paraíba
35 shared publications - Maria Angélica Sátyro Gomes Alves
Universidade Federal de Campina Grande
31 shared publications - Raline Mendonça dos Anjos
Universidade Federal de Campina Grande, Brasil
30 shared publications - Gymenna Maria Tenório Guênes
Universidade Federal de Campina Grande
28 shared publications - Millena de Souza Alves
Universidade Federal de Campina Grande, Brasil
24 shared publications - Elizandra Silva da Penha
Universidade Federal de Campina Grande
21 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by The ScienceIn Publishing in Journal of Integrated Science and Technology
- Vol. 14 (8) , 1619
In vitro antibacterial activity of trans-anethole against Gram-positive strains of food origin and in silico molecular docking study
The objective of this study was to evaluate the in vitro antibacterial activity of trans-anethole against foodborne Enterococcus faecium and Staphylococcus saprophyticus and to perform an in silico molecular docking study. Antibacterial activity was evaluated by determining the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), minimum inhibitory adhesion concentration (MIAC), and association of trans-anethole with conventional antimicrobials. Molecular docking was performed with the enzymes EfDap and UafA. The MIC of trans-anethole against E. faecium strains ranged from 500 μg/mL to 1000 μg/mL. Meanwhile, the MIC for S. saprophyticus strains was 1000 μg/mL. Trans-anethole showed MBC values >1000 μg/mL for all strains of E. faecium and S. saprophyticus. As for CIMA, trans-anethole was able to inhibit the bacterial biofilm of the E. faecium strain at a ratio of 1:8 and of the S. saprophyticus strain at a ratio of 1:2. Furthermore, in relation to E. faecium, trans-anethole had the best result when associated with the antimicrobial ciprofloxacin, as it presented a synergistic effect for all strains. For S. saprophyticus, trans-anethole had the best result when associated with the antimicrobials gentamicin, ampicillin, and penicillin. Furthermore, trans-anethole interacted with the active sites of EfDap and UafA with ΔG of -4.82 kcal/mol and ∆G of -3.64 kcal/mol, respectively. In conclusion, trans-anethole has antibacterial activity against foodborne E. faecium and S. saprophyticcus. Furthermore, molecular docking studies suggest that trans-anethole interacts moderately with the EfDap and UafA enzymes. Thus, trans-anethole shows potential as a promising antibacterial agent in combating foodborne bacterial infections.
- 30 June 2026
- Published by The ScienceIn Publishing in Journal of Integrated Science and Technology
- Vol. 14 (8) , 1619
Open AccessIn vitro antibacterial activity of trans-anethole against Gram-positive strains of food origin and in silico molecular docking study
The objective of this study was to evaluate the in vitro antibacterial activity of trans-anethole against foodborne Enterococcus faecium and Staphylococcus saprophyticus and to perform an in silico molecular docking study. Antibacterial activity was evaluated by determining the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), minimum inhibitory adhesion concentration (MIAC), and association of trans-anethole with conventional antimicrobials. Molecular docking was performed with the enzymes EfDap and UafA. The MIC of trans-anethole against E. faecium strains ranged from 500 μg/mL to 1000 μg/mL. Meanwhile, the MIC for S. saprophyticus strains was 1000 μg/mL. Trans-anethole showed MBC values >1000 μg/mL for all strains of E. faecium and S. saprophyticus. As for CIMA, trans-anethole was able to inhibit the bacterial biofilm of the E. faecium strain at a ratio of 1:8 and of the S. saprophyticus strain at a ratio of 1:2. Furthermore, in relation to E. faecium, trans-anethole had the best result when associated with the antimicrobial ciprofloxacin, as it presented a synergistic effect for all strains. For S. saprophyticus, trans-anethole had the best result when associated with the antimicrobials gentamicin, ampicillin, and penicillin. Furthermore, trans-anethole interacted with the active sites of EfDap and UafA with ΔG of -4.82 kcal/mol and ∆G of -3.64 kcal/mol, respectively. In conclusion, trans-anethole has antibacterial activity against foodborne E. faecium and S. saprophyticcus. Furthermore, molecular docking studies suggest that trans-anethole interacts moderately with the EfDap and UafA enzymes. Thus, trans-anethole shows potential as a promising antibacterial agent in combating foodborne bacterial infections.
- Open Access
- 28 May 2026
- Published by The ScienceIn Publishing in Journal of Integrated Science and Technology
- Vol. 14 (7)
Evaluation of the antibacterial activity of (R)-(+)-Limonene against strains of Enterococcus faecium isolated from food: an in vitro and in silico study
Microbial resistance demands new effective drugs, and phytotherapy emerges as an alternative by using medicinal plants to prevent and treat diseases. Thus, the present study aimed to evaluate the antimicrobial activity of (R)-(+)-Limonene against E. faecium strains isolated from food and its mechanism of action by molecular docking with the EfDAP enzyme. The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) techniques were performed by microdilution in 96-well plates, while the Minimum Inhibitory Adhesion Concentration (MIAC) was evaluated in test tubes. In addition, the association with antimicrobials was analysed by disc diffusion, and the molecular docking test was performed with AutoDock 4.2 software. The results showed MIC90 of 1000 μg/mL and MBC at ratios of 1:1 and 2:1, characterising bactericidal action. Regarding anti-adhesive activity, (R)-(+)-Limonene inhibited biofilm formation up to a ratio of 1:8. Regarding association with antimicrobials, it showed synergism with Gentamicin, Tetracycline, Ciprofloxacin, Amoxicillin, and Ceftriaxone. In addition, molecular interactions based on van der Waals forces and alkyl bonds with EfDAP were identified. These results indicate that the bioactive compounds present in essential oils and their derivatives have the potential to act as inhibitors of microorganisms, highlighting the need for further studies to evaluate their efficacy and possible therapeutic applications.
- 28 May 2026
- Published by The ScienceIn Publishing in Journal of Integrated Science and Technology
- Vol. 14 (7)
Open AccessEvaluation of the antibacterial activity of (R)-(+)-Limonene against strains of Enterococcus faecium isolated from food: an in vitro and in silico study
Microbial resistance demands new effective drugs, and phytotherapy emerges as an alternative by using medicinal plants to prevent and treat diseases. Thus, the present study aimed to evaluate the antimicrobial activity of (R)-(+)-Limonene against E. faecium strains isolated from food and its mechanism of action by molecular docking with the EfDAP enzyme. The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) techniques were performed by microdilution in 96-well plates, while the Minimum Inhibitory Adhesion Concentration (MIAC) was evaluated in test tubes. In addition, the association with antimicrobials was analysed by disc diffusion, and the molecular docking test was performed with AutoDock 4.2 software. The results showed MIC90 of 1000 μg/mL and MBC at ratios of 1:1 and 2:1, characterising bactericidal action. Regarding anti-adhesive activity, (R)-(+)-Limonene inhibited biofilm formation up to a ratio of 1:8. Regarding association with antimicrobials, it showed synergism with Gentamicin, Tetracycline, Ciprofloxacin, Amoxicillin, and Ceftriaxone. In addition, molecular interactions based on van der Waals forces and alkyl bonds with EfDAP were identified. These results indicate that the bioactive compounds present in essential oils and their derivatives have the potential to act as inhibitors of microorganisms, highlighting the need for further studies to evaluate their efficacy and possible therapeutic applications.
- Open Access
Xylan-Polyvinyl Alcohol Biopolymer Films Incorporated with Zanthoxylum rhoifolium Lam. Extract: Development, Characterization, and Antimicrobial Activity for Active Food Packaging
This study aimed to develop and characterize biodegradable films based on xylan and polyvinyl alcohol (PVA), incorporated with ethanolic extract of Zanthoxylum rhoifolium Lam., for application in active food packaging. A Box–Behnken experimental design was employed to optimize the concentrations of xylan, PVA, and glycerol, evaluating the mechanical properties of the films. The results indicated that glycerol reduced tensile strength and increased elongation at break, while higher concentrations of xylan and PVA promoted an increase in mechanical strength. FTIR and XRD analyses reveal structural change without the formation of new chemical structures. The Z. rhoifolium extract exhibited antibacterial activity with a minimum inhibitory concentration of 31.5 µg/mL for Klebsiella pneumoniae, increasing to 1000 µg/mL for Enterococcus faecium, Enterobacter cloacae, and Escherichia coli. In addition, hemolytic activity exceeded 80% at concentrations ≥ 1000 µg/mL, whereas concentrations up to 500 µg/mL can be considered safe, as hemolysis remained below 40%. The films incorporated with the extract showed antimicrobial activity, with emphasis on the formulation containing 60 mg of extract, which exhibited inhibition zones of up to 16 mm against Escherichia coli and 12 mm against Enterococcus faecalis. Thus, the results highlight the potential of functionalized xylan/PVA films as sustainable materials for the development of active packaging.
Open AccessXylan-Polyvinyl Alcohol Biopolymer Films Incorporated with Zanthoxylum rhoifolium Lam. Extract: Development, Characterization, and Antimicrobial Activity for Active Food Packaging
This study aimed to develop and characterize biodegradable films based on xylan and polyvinyl alcohol (PVA), incorporated with ethanolic extract of Zanthoxylum rhoifolium Lam., for application in active food packaging. A Box–Behnken experimental design was employed to optimize the concentrations of xylan, PVA, and glycerol, evaluating the mechanical properties of the films. The results indicated that glycerol reduced tensile strength and increased elongation at break, while higher concentrations of xylan and PVA promoted an increase in mechanical strength. FTIR and XRD analyses reveal structural change without the formation of new chemical structures. The Z. rhoifolium extract exhibited antibacterial activity with a minimum inhibitory concentration of 31.5 µg/mL for Klebsiella pneumoniae, increasing to 1000 µg/mL for Enterococcus faecium, Enterobacter cloacae, and Escherichia coli. In addition, hemolytic activity exceeded 80% at concentrations ≥ 1000 µg/mL, whereas concentrations up to 500 µg/mL can be considered safe, as hemolysis remained below 40%. The films incorporated with the extract showed antimicrobial activity, with emphasis on the formulation containing 60 mg of extract, which exhibited inhibition zones of up to 16 mm against Escherichia coli and 12 mm against Enterococcus faecalis. Thus, the results highlight the potential of functionalized xylan/PVA films as sustainable materials for the development of active packaging.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86
Antibacterial evaluation of (E)-3,7-dimethylocta-2,6-dien-1-yl acetate against Klebsiella pneumoniae strains: an in silico and in vitro study
Pressure ulcers (PUs) carry a high risk of infection by multidrug-resistant pathogens, including Klebsiella pneumoniae. This study evaluated the antibacterial activity of (E)-3,7-dimethylocta-2,6-dien-1-yl acetate (TSM-16), a synthetic derivative of geraniol, against various strains of K. pneumoniae. In silico analyses were performed using PASS online®, Molinspiration®, AutoDock, PyMol, and Discovery Studio, in addition to in vitro broth microdilution tests to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and disk diffusion assays to evaluate the combination of TSM-16 with conventional antibacterials. The in silico results indicated that TSM-16 complies with Lipinski’s Rule and has good bioavailability. In in vitro tests, the compound exhibited moderate to strong antibacterial activity (MIC 500-1000 µg/mL), a bacteriostatic profile (MBC >1000 µg/mL), and a predominance of synergistic effects when combined with synthetic antibacterials. These findings suggest that TSM-16 has potential as a safe antibacterial agent, serving as a basis for the development of new drugs against multidrug-resistant strains of K. pneumoniae.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86
Open AccessAntibacterial evaluation of (E)-3,7-dimethylocta-2,6-dien-1-yl acetate against Klebsiella pneumoniae strains: an in silico and in vitro study
Pressure ulcers (PUs) carry a high risk of infection by multidrug-resistant pathogens, including Klebsiella pneumoniae. This study evaluated the antibacterial activity of (E)-3,7-dimethylocta-2,6-dien-1-yl acetate (TSM-16), a synthetic derivative of geraniol, against various strains of K. pneumoniae. In silico analyses were performed using PASS online®, Molinspiration®, AutoDock, PyMol, and Discovery Studio, in addition to in vitro broth microdilution tests to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and disk diffusion assays to evaluate the combination of TSM-16 with conventional antibacterials. The in silico results indicated that TSM-16 complies with Lipinski’s Rule and has good bioavailability. In in vitro tests, the compound exhibited moderate to strong antibacterial activity (MIC 500-1000 µg/mL), a bacteriostatic profile (MBC >1000 µg/mL), and a predominance of synergistic effects when combined with synthetic antibacterials. These findings suggest that TSM-16 has potential as a safe antibacterial agent, serving as a basis for the development of new drugs against multidrug-resistant strains of K. pneumoniae.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86, e303373
Anticoagulant, antioxidant and cytotoxic potential of cinnamic acid and derivatives
Introduction Since antiquity, natural products have been widely used to relieve symptoms and prevent numerous diseases. Early treatments for vascular disorders, including thrombosis, relied heavily on plant-derived substances, which later served as prototypes for the development of platelet aggregation inhibitors and coagulation-modulating agents. Among these bioactive constituents, phenolic compounds—abundantly found in various botanical sources—have gained prominence due to their well-established antioxidant properties and reported anticoagulant effects. Recent studies highlight that the structural diversity of phenolic acids, particularly cinnamic acid (CA) and its derivatives, offers a valuable chemical scaffold for developing new therapeutic agents targeting thrombogenesis and oxidative imbalance. Objective This study aimed to evaluate, in vitro, the pharmacological (anticoagulant and antioxidant) and toxicological (oxidant and cytotoxic) activities of cinnamic acid (CA) and five synthetic derivatives—4HDCN, 4MTCN, 3,4DHCN, 3,4DMCN, and 3H4MCN. Methods Anticoagulant activity was assessed using a semi-automated coagulometer by measuring clotting time after exposure of human plasma to each molecule. Antioxidant, oxidant, and cytotoxic (hemolytic) activities were determined using human erythrocytes from blood groups A, B, and O. Oxidative and antioxidant responses were quantified by spectrophotometry following exposure to phenylhydrazine as a pro-oxidant inducer. Hemolysis was evaluated at concentrations ranging from 0 to 400 mg/dL. Results In the anticoagulant assays, the derivative 3,4DHCN exhibited the strongest activity, prolonging clotting time to 176.6 s, slightly surpassing 3,4MTCN (165.6 s). All molecules demonstrated low or negligible oxidizing activity (<7.1%). Regarding antioxidant potential, 4MTCN showed the most effective protection against phenylhydrazine-induced oxidation, reducing oxidative damage to 8.7%. None of the tested compounds induced moderate or high hemolysis at concentrations up to 200 mg/dL. However, at 400 mg/dL, CA and 4HDCN produced high hemolytic rates across erythrocyte types. In type A cells, hemolysis reached 89.4% (CA) and 76.0% (4HDCN); in type B, 64.3% and 60.5%; and in type O, 90.1% and 70.7%, respectively. Conclusion Dihydroxylated and dimethoxylated cinnamic acid derivatives demonstrated notable anticoagulant activity, minimal oxidative effects, low antioxidant capacity, and an absence of cytotoxicity in human erythrocytes at therapeutically relevant concentrations. These findings indicate that such molecules represent promising candidates for the development of new anticoagulant agents with favorable safety profiles.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86, e303373
Open AccessAnticoagulant, antioxidant and cytotoxic potential of cinnamic acid and derivatives
Introduction Since antiquity, natural products have been widely used to relieve symptoms and prevent numerous diseases. Early treatments for vascular disorders, including thrombosis, relied heavily on plant-derived substances, which later served as prototypes for the development of platelet aggregation inhibitors and coagulation-modulating agents. Among these bioactive constituents, phenolic compounds—abundantly found in various botanical sources—have gained prominence due to their well-established antioxidant properties and reported anticoagulant effects. Recent studies highlight that the structural diversity of phenolic acids, particularly cinnamic acid (CA) and its derivatives, offers a valuable chemical scaffold for developing new therapeutic agents targeting thrombogenesis and oxidative imbalance. Objective This study aimed to evaluate, in vitro, the pharmacological (anticoagulant and antioxidant) and toxicological (oxidant and cytotoxic) activities of cinnamic acid (CA) and five synthetic derivatives—4HDCN, 4MTCN, 3,4DHCN, 3,4DMCN, and 3H4MCN. Methods Anticoagulant activity was assessed using a semi-automated coagulometer by measuring clotting time after exposure of human plasma to each molecule. Antioxidant, oxidant, and cytotoxic (hemolytic) activities were determined using human erythrocytes from blood groups A, B, and O. Oxidative and antioxidant responses were quantified by spectrophotometry following exposure to phenylhydrazine as a pro-oxidant inducer. Hemolysis was evaluated at concentrations ranging from 0 to 400 mg/dL. Results In the anticoagulant assays, the derivative 3,4DHCN exhibited the strongest activity, prolonging clotting time to 176.6 s, slightly surpassing 3,4MTCN (165.6 s). All molecules demonstrated low or negligible oxidizing activity (<7.1%). Regarding antioxidant potential, 4MTCN showed the most effective protection against phenylhydrazine-induced oxidation, reducing oxidative damage to 8.7%. None of the tested compounds induced moderate or high hemolysis at concentrations up to 200 mg/dL. However, at 400 mg/dL, CA and 4HDCN produced high hemolytic rates across erythrocyte types. In type A cells, hemolysis reached 89.4% (CA) and 76.0% (4HDCN); in type B, 64.3% and 60.5%; and in type O, 90.1% and 70.7%, respectively. Conclusion Dihydroxylated and dimethoxylated cinnamic acid derivatives demonstrated notable anticoagulant activity, minimal oxidative effects, low antioxidant capacity, and an absence of cytotoxicity in human erythrocytes at therapeutically relevant concentrations. These findings indicate that such molecules represent promising candidates for the development of new anticoagulant agents with favorable safety profiles.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86, e304908
(R)-(+)-limonene: a promising antifungal agent against Candida glabrata
Fungal infections of the genus Candida are among the most common in the world and, consequently, resistance to existing antifungal agents is a very challenging reality. In this sense, medicinal plant-based substances can aid in the design of pharmacologically important products and contribute to the development of innovative therapeutic alternatives. Given this, the objective of this study was to investigate the antifungal potential of the monoterpene (R)-(+)-limonene against strains of Candida glabrata (Nakaseomyces glabrata). Antifungal activity was determined by the broth microdilution technique for the minimum inhibitory concentration (MIC) and, subsequently, the minimum fungicidal concentration (MFC) was determined. The mechanism of action of the possible antifungal activity was analyzed by sorbitol and ergosterol assays. Molecular docking was also performed to evaluate the molecular interactions of (R)-(+)-Limonene with the enzyme 1,3-β-glucanase and sterol 14α-demethylase. Based on the tests, (R)-(+)-Limonene presented a MIC and MFC of 256 μg/mL, with fungicidal characteristics, showing strong inhibitory activity for strains ATCC 9003, LM 13, and LM 16 and moderate activity for LM 46. The mechanism of action involves both the cell wall and the fungal plasma membrane. In addition, the molecular docking study pointed to an interaction between (R)-(+)-Limonene and the active sites of the proteins 1,3-β-glucanase and sterol 14α-demethylase (CYP51), the latter being more robust. As for the association test, the antifungal potential of (R)-(+)-Limonene was demonstrated when used individually, without association with fluconazole. Based on these findings, it can be concluded that (R)-(+)-Limonene is a very promising monoterpene for the development of new drugs for the treatment of candidiasis caused by Candida glabrata (Nakaseomyces glabrata).
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86, e304908
Open Access(R)-(+)-limonene: a promising antifungal agent against Candida glabrata
Fungal infections of the genus Candida are among the most common in the world and, consequently, resistance to existing antifungal agents is a very challenging reality. In this sense, medicinal plant-based substances can aid in the design of pharmacologically important products and contribute to the development of innovative therapeutic alternatives. Given this, the objective of this study was to investigate the antifungal potential of the monoterpene (R)-(+)-limonene against strains of Candida glabrata (Nakaseomyces glabrata). Antifungal activity was determined by the broth microdilution technique for the minimum inhibitory concentration (MIC) and, subsequently, the minimum fungicidal concentration (MFC) was determined. The mechanism of action of the possible antifungal activity was analyzed by sorbitol and ergosterol assays. Molecular docking was also performed to evaluate the molecular interactions of (R)-(+)-Limonene with the enzyme 1,3-β-glucanase and sterol 14α-demethylase. Based on the tests, (R)-(+)-Limonene presented a MIC and MFC of 256 μg/mL, with fungicidal characteristics, showing strong inhibitory activity for strains ATCC 9003, LM 13, and LM 16 and moderate activity for LM 46. The mechanism of action involves both the cell wall and the fungal plasma membrane. In addition, the molecular docking study pointed to an interaction between (R)-(+)-Limonene and the active sites of the proteins 1,3-β-glucanase and sterol 14α-demethylase (CYP51), the latter being more robust. As for the association test, the antifungal potential of (R)-(+)-Limonene was demonstrated when used individually, without association with fluconazole. Based on these findings, it can be concluded that (R)-(+)-Limonene is a very promising monoterpene for the development of new drugs for the treatment of candidiasis caused by Candida glabrata (Nakaseomyces glabrata).
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86, e302367
Antibacterial and toxicological evaluation of (E)-2-((3,7-dimethylocta-2,6-dien-1-yl)oxy)ethyl acetate
Klebsiella pneumoniae is a Gram-negative bacterium of great clinical relevance, responsible for severe infections and frequently associated with multidrug resistance. In this context, the synthesis of derivatives from natural products emerges as a promising alternative for the development of new compounds with biological and pharmacological potential. In the search for new compounds, the present study aimed to evaluate the antibacterial activity of (E)-2-((3,7-dimethylocta-2,6-dien-1-yl)oxy)ethyl acetate against K. pneumoniae strains. To achieve this goal, in silico methodologies were employed using the software PASS online®, Molinspiration®, admetSAR®, and molecular docking. For the in vitro studies, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined using 96-well plates, along with combination tests with conventional synthetic antibacterials through disk diffusion. The main results of this study indicated that TSM-17 exhibited low theoretical toxicity. Through molecular docking, it was possible to observe the interaction of TSM-17 with the enzymatic active site of topoisomerase IV. The MIC of TSM-17 ranged from 250 µg/mL to 500 µg/mL against K. pneumoniae strains, indicating good antimicrobial activity, and it also showed bactericidal activity against most strains. Furthermore, the combination of TSM-17 with conventional antimicrobials, especially tetracycline, gentamicin, and cephalothin, resulted in synergistic effects, enhancing its efficacy. Thus, this study highlights the potential of the TSM-17 compound as a promising candidate for the development of new antibacterial agents against K. pneumoniae and reinforces the relevance of natural product-derived compounds in the search for new therapeutic alternatives to combat antimicrobial resistance.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86, e302367
Open AccessAntibacterial and toxicological evaluation of (E)-2-((3,7-dimethylocta-2,6-dien-1-yl)oxy)ethyl acetate
Klebsiella pneumoniae is a Gram-negative bacterium of great clinical relevance, responsible for severe infections and frequently associated with multidrug resistance. In this context, the synthesis of derivatives from natural products emerges as a promising alternative for the development of new compounds with biological and pharmacological potential. In the search for new compounds, the present study aimed to evaluate the antibacterial activity of (E)-2-((3,7-dimethylocta-2,6-dien-1-yl)oxy)ethyl acetate against K. pneumoniae strains. To achieve this goal, in silico methodologies were employed using the software PASS online®, Molinspiration®, admetSAR®, and molecular docking. For the in vitro studies, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined using 96-well plates, along with combination tests with conventional synthetic antibacterials through disk diffusion. The main results of this study indicated that TSM-17 exhibited low theoretical toxicity. Through molecular docking, it was possible to observe the interaction of TSM-17 with the enzymatic active site of topoisomerase IV. The MIC of TSM-17 ranged from 250 µg/mL to 500 µg/mL against K. pneumoniae strains, indicating good antimicrobial activity, and it also showed bactericidal activity against most strains. Furthermore, the combination of TSM-17 with conventional antimicrobials, especially tetracycline, gentamicin, and cephalothin, resulted in synergistic effects, enhancing its efficacy. Thus, this study highlights the potential of the TSM-17 compound as a promising candidate for the development of new antibacterial agents against K. pneumoniae and reinforces the relevance of natural product-derived compounds in the search for new therapeutic alternatives to combat antimicrobial resistance.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86, e304325
Antibacterial potential of Citrus sinensis essential oil against foodborne pathogens: a systematic review
Bacteria are single-celled, prokaryotic organisms that can be present in contaminated food, causing various waterborne and foodborne diseases (WBD), which generate high morbidity rates and, in more severe cases, mortality in various regions of the world. The growing increase in bacterial resistance to antimicrobials used in the food industry and public health represents a serious health challenge, making the search for new microbial control strategies urgent. In this context, natural products, such as essential oils, have gained prominence for their bioactive compounds with significant antimicrobial potential, such as the terpenes found in Citrus sinensis (sweet orange) essential oil, which have been shown to be effective against various pathogenic bacteria involved in WFDIs. The objective of the study was to conduct a systematic review to evaluate the therapeutic potential of Citrus sinensis essential oil against foodborne pathogenic bacteria. The search covered documents in Portuguese and English published between 2019 and 2024. Data were collected through CAPES electronic journal platforms, using the Embase, PubMed, and Web of Science databases. The studies were organized and managed with the help of Mendeley software. Initially, 1,562 articles were found. After applying exclusion criteria and refining the search, 12 studies were selected for this review. It was observed that Citrus sinensis essential oil, both alone and in combination with other compounds, demonstrated significant antibacterial activity against gram-positive and gram-negative strains. Citrus sinensis essential oil appears to be a promising alternative in combating pathogenic bacteria, although further studies are needed to elucidate its mechanism of action and broaden its spectrum of application.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86, e304325
Open AccessAntibacterial potential of Citrus sinensis essential oil against foodborne pathogens: a systematic review
Bacteria are single-celled, prokaryotic organisms that can be present in contaminated food, causing various waterborne and foodborne diseases (WBD), which generate high morbidity rates and, in more severe cases, mortality in various regions of the world. The growing increase in bacterial resistance to antimicrobials used in the food industry and public health represents a serious health challenge, making the search for new microbial control strategies urgent. In this context, natural products, such as essential oils, have gained prominence for their bioactive compounds with significant antimicrobial potential, such as the terpenes found in Citrus sinensis (sweet orange) essential oil, which have been shown to be effective against various pathogenic bacteria involved in WFDIs. The objective of the study was to conduct a systematic review to evaluate the therapeutic potential of Citrus sinensis essential oil against foodborne pathogenic bacteria. The search covered documents in Portuguese and English published between 2019 and 2024. Data were collected through CAPES electronic journal platforms, using the Embase, PubMed, and Web of Science databases. The studies were organized and managed with the help of Mendeley software. Initially, 1,562 articles were found. After applying exclusion criteria and refining the search, 12 studies were selected for this review. It was observed that Citrus sinensis essential oil, both alone and in combination with other compounds, demonstrated significant antibacterial activity against gram-positive and gram-negative strains. Citrus sinensis essential oil appears to be a promising alternative in combating pathogenic bacteria, although further studies are needed to elucidate its mechanism of action and broaden its spectrum of application.
- 30 November 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (2) , e01237
Phytochemical Characterization, Antioxidant, and Photoprotective Activities of Pseudobombax simplicifolium A. Robyns
Plants of the genus Pseudobombax Dugand (Malvaceae) exhibit a wide range of medicinal properties, including antioxidant, anti‐inflammatory, antinociceptive, antimicrobial, and anticancer activities. This study is the first to analyze the phytochemical composition, antioxidant properties, and sun protection factor (SPF) of Pseudobombax simplicifolium . Phytochemical tests of the hydroalcoholic extracts from the stem barks (HEB) and leaves (HEL) of P. simplicifolium indicated the presence of saponins, phenolic compounds, tannins, flavonoids, alkaloids, steroids, and terpenoids. Chromatographic fractionation of the HEB and HEL resulted in isolating of the three known compounds lupeol, β‐sitosterol, and lup‐20(29)‐en‐3β‐28‐diol that are being reported here for the first time in this species. The extracts and fractions exhibited antioxidant activity as measured by the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) (IC 50 = 14.85 ± 0.15 for HEB‐F9), 2,2‐azinobis‐3‐ethylbenzothiazoline‐6‐sulfonic acid (ABTS) (IC 50 = 27.47 ± 0.53 for HEB‐F9), and total antioxidant capacity (TAC) (IC 50 = 627.43 ± 2.16 for HEB‐F9) assays. Additionally, the HEB and its fractions demonstrated photoprotective activity against ultraviolet radiation, with SPF values of 25.01 at concentrations as low as 50 µg mL, exceeding the minimum SPF required by regulations. LC–MS analysis of the HEB and its fractions identified a variety of compounds phenolic, which are likely responsible for the observed activities.
- 30 November 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (2) , e01237
Phytochemical Characterization, Antioxidant, and Photoprotective Activities of Pseudobombax simplicifolium A. Robyns
Plants of the genus Pseudobombax Dugand (Malvaceae) exhibit a wide range of medicinal properties, including antioxidant, anti‐inflammatory, antinociceptive, antimicrobial, and anticancer activities. This study is the first to analyze the phytochemical composition, antioxidant properties, and sun protection factor (SPF) of Pseudobombax simplicifolium . Phytochemical tests of the hydroalcoholic extracts from the stem barks (HEB) and leaves (HEL) of P. simplicifolium indicated the presence of saponins, phenolic compounds, tannins, flavonoids, alkaloids, steroids, and terpenoids. Chromatographic fractionation of the HEB and HEL resulted in isolating of the three known compounds lupeol, β‐sitosterol, and lup‐20(29)‐en‐3β‐28‐diol that are being reported here for the first time in this species. The extracts and fractions exhibited antioxidant activity as measured by the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) (IC 50 = 14.85 ± 0.15 for HEB‐F9), 2,2‐azinobis‐3‐ethylbenzothiazoline‐6‐sulfonic acid (ABTS) (IC 50 = 27.47 ± 0.53 for HEB‐F9), and total antioxidant capacity (TAC) (IC 50 = 627.43 ± 2.16 for HEB‐F9) assays. Additionally, the HEB and its fractions demonstrated photoprotective activity against ultraviolet radiation, with SPF values of 25.01 at concentrations as low as 50 µg mL, exceeding the minimum SPF required by regulations. LC–MS analysis of the HEB and its fractions identified a variety of compounds phenolic, which are likely responsible for the observed activities.
- Open Access
- 26 September 2025
- Published by Zeppelini Editorial e Comunicacao in Food Science and Technology
- Vol. 45
Functional activities and applications of Pequi Oil: a systematic review and meta-analysis
Pequi oil is a promising raw material known for its high content of unsaturated fatty acids, polyphenols, and carotenoids. This systematic review focuses on its potential and industrial applications. A total of 27 studies were selected, and 14 were meta-analyzed. The results demonstrated the oil’s potential in the food industry, where natural antioxidants served as preservatives, stabilizers, and additives, thereby extending the shelf life of products like yogurt and cheese. Additionally, pequi oil has applications in pharmaceuticals, phyto-cosmetics, as well as in nano-emulsions and nanocomposites. The meta-analysis revealed a total effect size of 0.73 with a 95% confidence interval of 0.67–0.79 and a significant p-value (p < .01). Heterogeneity was observed (I2 = 95%; p < .0011), supporting the practical application of pequi oil in various therapeutic interventions. These include antioxidant, anti-inflammatory, antigenotoxic, and anticarcinogenic effects, as well as potential treatments for diseases related to oxidative stress, glycemic control, anemia, reduction of low-density lipoproteins cholesterol, osteoarthritis symptoms, and dermal wound healing. Pequi oil shows considerable potential for product development across various industrial sectors. However, it is essential to explore alternative methods of its exploitation to expand its practical applications and foster new product development.
- 26 September 2025
- Published by Zeppelini Editorial e Comunicacao in Food Science and Technology
- Vol. 45
Open AccessFunctional activities and applications of Pequi Oil: a systematic review and meta-analysis
Pequi oil is a promising raw material known for its high content of unsaturated fatty acids, polyphenols, and carotenoids. This systematic review focuses on its potential and industrial applications. A total of 27 studies were selected, and 14 were meta-analyzed. The results demonstrated the oil’s potential in the food industry, where natural antioxidants served as preservatives, stabilizers, and additives, thereby extending the shelf life of products like yogurt and cheese. Additionally, pequi oil has applications in pharmaceuticals, phyto-cosmetics, as well as in nano-emulsions and nanocomposites. The meta-analysis revealed a total effect size of 0.73 with a 95% confidence interval of 0.67–0.79 and a significant p-value (p < .01). Heterogeneity was observed (I2 = 95%; p < .0011), supporting the practical application of pequi oil in various therapeutic interventions. These include antioxidant, anti-inflammatory, antigenotoxic, and anticarcinogenic effects, as well as potential treatments for diseases related to oxidative stress, glycemic control, anemia, reduction of low-density lipoproteins cholesterol, osteoarthritis symptoms, and dermal wound healing. Pequi oil shows considerable potential for product development across various industrial sectors. However, it is essential to explore alternative methods of its exploitation to expand its practical applications and foster new product development.